A-Share Listed Pharmaceutical Companies - Profiles and Financial Data 201

With growing Chinese economy and increasing residents' income, people's purchasing power of pharmaceuticals has been enhanced. China's aging population also promotes demand for pharmaceuticals. In 2016, revenues from main businesses of China's pharmaceutical industry reached CNY 2,963.59 billion, up by 9.9% YOY; profits were CNY 321.64 billion, up by 15.6% YOY. Among sub-industries, active pharmaceutical ingredients (API) , pharmaceutical preparations and medical devices maintained strong profitability, witnessing their profits grow by 25.9%, 16.8% and 32.3%, respectively. The revenues from main businesses of pharmaceutical preparations, TCM decoction pieces processing, sanitary materials & medical products and medical devices industries were higher than average and grew by 10.8%, 12.7%, 11.5% and 13.3%, respectively.

For more information about this report at
http://www.reportsweb.com/a-share-listed-pharmaceutical-companies-profiles-and-financial-data

In 2016, the revenue of the chemical pharmaceutical industry reached CNY 1,256.96 billion, up by 9.9% YOY; profits were CNY 139.57 billion, up by 19.6% YOY; export delivery value was CNY 79.26 billion, up by 4.5% YOY. The operating revenue of API manufacturers totaled to CNY 503.49 billion, up by 8.4% YOY; profits were CNY 44.53 billion, up by 25.9% YOY; export delivery value was CNY 64.87 billion, up by 7.4% YOY.
CRI expects that in the next few years, demand for pharmaceuticals will rise with increasing residents' income, upgrading consumption, aging population, accelerating urbanization and improving healthcare system, promoting the development of China's pharmaceutical industry.
In this report, CRI analyzes 161 pharmaceutical enterprises listed in A-share market in China.

Request a sample copy at
http://www.reportsweb.com/inquiry&RW0001774348/sample

The report is composed of two parts: the first part is enterprise profiles and the second part is the operation status of these enterprises in the recent decade (presently 2006 to 2016, we will update it to the latest as time goes by).
The operation status is demonstrated from the following perspectives: (1) financial indexes, such as earnings per share, book value per share (BPS) , sales per share, net cash flow per share, return on net worth and debt to asset ratio; (2) indexes on the income statement, such as revenue, operating profit, net profit and EBIT; (3) indexes on the income statement, such as revenue, operating profit, net profit and EBIT; (4) indexes on the balance sheet, such as liquid asset, fixed asset, current liability, non-current liability, capital reserve and shareholders' equity.

1) Financial Indexes
- Earnings per Share
- Book Value per Share (BPS)
- Sales per Share (SPS)
- Net Cash Flow per Share from Operations
- Net Cash Flow per Share (CNY)
- Return on Net Worth
- Net Profit Margin on Total Assets
- Return on Invested Capital (ROIC) (%)
- Gross Profit Margin on Sales (%)
- Net Profit Margin on Sales (%)
- EBIT Margin (%)
- EBITDA Margin (%)
- Debt to Asset Ratio (%)
- Total Asset Turnover (times)
- Cash/Operating Income Received from Sales of Goods or Services
- YOY Growth Rate of Operating Revenue (%)
- YOY Growth Rate of Operating Profit (%)
- YOY Growth Rate of Net Profit Attributable to Shareholders of Parent Company (%)

Ask for Discount at
http://www.reportsweb.com/inquiry&RW0001774348/discount

(2) Summary of Income Statement
- Gross Revenue (CNY, million)
- Total Operating Costs (CNY, million)
- Revenue (CNY, million)
- Operating Profit (CNY, million)
- Total Profit (CNY, million)

(3) Summary of Balance Sheet
- Liquid Asset (CNY, million)
- Fixed Asset (CNY, million)
- Long-term Equity Investment
- Total Assets (CNY, million)
- Liquid Liability (CNY, million)
- Non-current Liability (CNY, million)

(4) Summary of Cash Flow Statement
- Cash Received from Sales of Goods and Services (CNY, million)
- Cash Flow from Operations (CNY, million)
- Cash Paid to Purchase Fixed Assets, Intangible Assets and Other Long-term Assets (CNY, million)
- Cash Paid for Investments (CNY, million)
- Cash Flow from Investments (CNY, million)
- Cash Received from Investors (CNY, million)

Contact Us:
Call: +1-646-491-9876
Email: sales@reportsweb.com

ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

Pune:
505, 6th floor, Amanora Township,
Amanora Chambers, East Block,
Kharadi Road, Hadapsar, Pune-411028

This release was published on openPR.